Log In
Print this Print this

Brimica Genuair, Duaklir Genuair, Aclidinium bromide/formoterol fumarate (KRP-AB1102F, LAS40464)

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionFixed-dose combination of aclidinium bromide with the long acting beta agonist (LABA) formoterol
Molecular Target Adrenergic receptor beta 2 (ADRB2) ; Muscarinic receptor
Mechanism of ActionAdrenergic receptor beta 2 (ADRB2) agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat chronic obstructive pulmonary disease (COPD)
Regulatory Designation EU - Standard Review (Treat chronic obstructive pulmonary disease (COPD))
Partner Allergan plc; Kyorin Pharmaceutical Co. Ltd.; Menarini Group

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today